<DOC>
	<DOC>NCT02090127</DOC>
	<brief_summary>Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient</brief_summary>
	<brief_title>Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient</brief_title>
	<detailed_description>This treatment protocol will serve as a mechanism to continue to provide ficlatuzumab to patient 0001-000412, who was previously enrolled under protocol P05538 and whom the investigator believes is deriving clinical benefit from ficlatuzumab treatment.</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Mixed Tumor, Mullerian</mesh_term>
	<criteria>Per original P05538 protocol Per original P05538 protocol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>